Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study.
about
Nasal Crohn's disease /apheresisAn open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's diseaseInfliximab- and immunosuppressant-resistant Crohn's disease successfully treated with adsorptive granulocyte apheresis combined with prednisoloneCytapheresis in inflammatory bowel diseases: current evidence and perspectives.Leukocytapheresis for the treatment of IBD.Granulocytapheresis in the treatment of patients with active ulcerative colitis.Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitisImmunological status of the stomach in inflammatory bowel disease--comparison between ulcerative colitis and Crohn's disease.Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.Relationships between Helicobacter pylori infection status, endoscopic, histopathological findings, and cytokine production in the duodenum of Crohn's disease patients.Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.
P2860
Q34940554-BEAF906D-4001-4999-8824-CBF293F2C6A5Q35846531-ED23ED27-A4A8-4715-8B64-A19A37D3BBA7Q36072095-8EF8FBAF-1501-40F4-A685-3F63263EB905Q37125624-0E86D13A-A14C-4776-970C-BF62E7FCCDCBQ37229788-67E08625-3E9C-480E-B181-5C26A56F12E0Q37345830-E0ED317F-AD1A-480A-9546-75E77A9D938AQ37347061-D3AA6A1D-8E46-4CC9-A0F8-29E999AF6B8CQ43719939-3A082E8A-F65B-4D49-9CC3-4DFFE077596BQ45072930-078CE64A-1AA5-4A83-8CC3-FC3FF1B5811DQ46176620-808A31CB-D418-4847-A280-2CE39388D3E7Q46341671-EDD83FC2-C15B-4D01-A178-FE2A5CE4AA9BQ47694487-23FD7795-FE91-4A8D-9251-40796704DF1FQ48420954-950A29F7-F1BD-49A4-B7ED-A07EE116D2F4
P2860
Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Treatment of active steroid-re ...... ence with a prospective study.
@ast
Treatment of active steroid-re ...... ence with a prospective study.
@en
type
label
Treatment of active steroid-re ...... ence with a prospective study.
@ast
Treatment of active steroid-re ...... ence with a prospective study.
@en
prefLabel
Treatment of active steroid-re ...... ence with a prospective study.
@ast
Treatment of active steroid-re ...... ence with a prospective study.
@en
P2093
P2860
P356
P1476
Treatment of active steroid-re ...... ence with a prospective study.
@en
P2093
Bertoni Michele
Bresci Giampaolo
Capria Alfonso
Mazzoni Alessandro
Parisi Giuseppe
Scatena Fabrizio
P2860
P304
P356
10.3748/WJG.V12.I14.2201
P407
P577
2006-04-01T00:00:00Z